학술논문
First report of the randomized phase III study of bi-weekly trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) vs. FTD/TPI monotherapy for chemorefractory metastatic colorectal cancer (mCRC): JCOG2014 (ROBiTS).
Document Type
Article
Author
Satake, Hironaga; Yamazaki, Kentaro; Suwa, Yusuke; Tsushima, Takahiro; Ishizuka, Yasunobu; Boku, Shogen; Takashima, Atsuo; Yamaguchi, Toshifumi; Asayama, Masako; Yokota, Mitsuru; Numata, Koji; Ohta, Takashi; Yasui, Hisateru; Kito, Yosuke; Takii, Yasumasa; Kitabayashi, Ryo; Sano, Yusuke; Fukuda, Haruhiko; Hamaguchi, Tetsuya; Kanemitsu, Yukihide
Source
Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p118-118, 235p
Subject
Language
ISSN
0732183X